Azidothymidine enhances fluorodeoxyuridine-mediated radiosensitization.
Chang-Ming Chen1, Monika Johnson, Brian J Smith
1Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 55805, USA.
International Journal of Radiation Oncology, Biology, Physics
|February 18, 2010
Summary
Azidothymidine (AZT), a thymidine analogue, enhances radiation therapy effectiveness during thymidine deprivation. This combination increases DNA damage and cell death, suggesting DNA strand breaks are key to radiosensitization.
Area of Science:
- Molecular Biology
- Radiation Oncology
- Cancer Research
Background:
- Thymidine analogues are used in cancer therapy.
- DNA repair mechanisms influence treatment response.
- Understanding radiosensitization is crucial for optimizing radiation therapy.
Purpose of the Study:
- To investigate how DNA repair and thymidine analogues affect radiation response during thymidine deprivation.
- To evaluate the role of mismatch repair (MMR) in thymidine analogue toxicity and radiosensitization.
Main Methods:
- Utilized mismatch repair-deficient (HEC59) and proficient (HC-2.4) cell lines.
- Treated cells with fluorodeoxyuridine (FUdR), azidothymidine (AZT), and irradiation, alone and in combination.
- Assessed clonogenic survival and cell-cycle distribution to determine treatment outcomes.
Main Results:
- Mismatch repair deficiency (hMSH2) did not significantly impact thymidine deprivation toxicity or radiosensitization.
- Azidothymidine (AZT) increased fluorodeoxyuridine (FUdR) toxicity and induced DNA fragmentation.
- The combination of FUdR and AZT demonstrated superior radiosensitization compared to either agent alone, with enhancement ratios up to 1.8.
Conclusions:
- Azidothymidine (AZT), a chain-terminating thymidine analogue, potentiates the radiosensitizing effects of thymidine deprivation.
- Deoxyribonucleic acid strand breaks are likely critical mediators of thymidine deprivation-induced radiosensitization.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...